Evaluation of the Efficacy of National Cancer Institute's Facing Forward Booklet in the Cancer Community Setting
Completed · Not applicable
Conditions studied: Prostate Cancer, Breast Cancer, Colorectal Cancer, Thoracic Cancer
In brief
This study was designed to provide a preliminary evaluation of the efficacy and usability of the 2004 revised version of the booklet, Facing Forward , Life After Cancer Treatment, (hereafter,Facing Forward) published by the National Cancer Institute. Facing Forward provides early stage cancer patients during the period after completing active treatment practical ways of dealing with common problems, including guidelines for managing physical, social, and emotional health. Assessments were completed at the patient's final cancer treatment visit. Follow-up assessments occurred eight weeks and 6 months later. The initial assessments covered background information (demographics, medical status), use of educational materials, survivorship activities, and psychological factors. The follow-up assessments included use of actions recommended in Facing Forward, ratings of Facing Forward with respect the booklet's informativeness, helpfulness, understandability, and extent read, the same psychological measures used initially, and a measure of self-efficacy.
Key facts
- Study ID
- NCT01440855
- Run by
- Fox Chase Cancer Center
- People needed
- 340
- Starts
- 2005-02-01
- Expected to finish
- 2009-10-01
- Last updated by the study team
- 2011-10-04
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- current age at or above 18 years;
- breast, colorectal, prostate, and/or thoracic cancer diagnosis,stage I, II, IIIa;
- approaching or attending the last treatment appointment of chemotherapy and or radiation therapy for the cancer diagnosis
- English speaking (able to read English at an 8th grade level);
- have a mailing address;
- have residential phone service;
- able to give informed consent.
You may not qualify if…
- patients who have received surgery only with no adjuvant therapy;
- second primary cancer or recurrent disease;
- patients receiving brachytherapy only
Where it is running
- Fox Chase Cancer Center — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.